Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports Post date 4 October 2021 ← Covid-19: Chikwe Ihekweazu: “It’s a rare privilege” to lead new pandemic hub → Government promises 40 new diagnostic centres to tackle backlog